Mountain Valley MD (MVMD:CSE) Catches Small Cap Fire After Ivermectin Testimony In US Senate Called "Miraculous Effectiveness" In Prohibiting Transmission Of COVID-19

"It basically obliterates transmission of this virus" This  was the testimony of  Pierre Kory, M.D., Associate Professor of  Medicine at St. Luke's Aurora Medical Center, delivers passionate  testimony during the Senate Homeland Security and Governmental Affairs  Committee hearing on "Early Outpatient Treatment: An Essential Part of a  COVID-19 Solution, Part II." We interviewed  Leigh Hughes, newly appointed Advisor to MVMD who will be supporting the  Company in the areas of M&A, corporate finance and pharmaceutical  licensing, to provide us with further insight as to why the testimony of  Dr. Kory is so relevant to MVMD ... and why Dr. Kory actually called  MVMD last week to discuss the Company's involvement with Ivermectin. Mountain  Valley MD has traded over 50,000,000 shares in the last 3 trading days,  so there is a clear need for information amongst retail investors.